forecast
Biotech Is Now Entering Cheap Entry Point
Crowley argues that despite a tough three years, the next generation of university-spun technologies and a queue of higher-quality companies entering the IPO market at reasonable valuations makes the present a strong entry point for investors.
forecastpending
Speaker
John CrowleyEvidence Quote
“there's never been a more exciting time to be in or to be associated with or to be investing in biotechnology”
Created: 11/18/2026, 9:59:31 AM
Your notes
Loading notes...